May 2021- VistaGen Therapeutics announced the initiation of its PALISADE Phase-3 clinical program to test the efficacy and safety of PH94B for the acute treatment of social anxiety disorder among adults.
November 2020- Janssen Pharmaceuticals, a company of Johnson & Johnson, collaborated with Koa Health to research ways for pairing the delivery of digital cognitive behavioral therapy with pharmacological treatments to help patients with major depressive disorder.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?